[ad_1]
In addition, the Israeli health fund Maccabi, which analyzed the data, reported that 50 percent of those infected, that is, 10 people, suffer from chronic diseases. However, no complications were recorded.
Already vaccinated, less than 0.01 percent infected. vaccinated people, but even this pinch did not get sick. Pfizer / BioNTech has previously said that the vaccine could be as effective as 95%, but a study in Israel suggests that the results could be even better.
It is true that this is preliminary data and it is too early to draw conclusions simply because it has been more than a week since the first day that people received the second dose of the vaccine.
Scanpix / Xinhua / Photo by ZUMA Press / Vaccination against COVID-19 in Israel
Furthermore, the data comes from a time when Israel, like many other countries, has announced restrictions on public life when people communicate and move less.
However, there is no shortage of optimism, especially since Israel is the world leader in vaccination rates against the coronavirus. The country has reached an agreement with Pfizer to provide the company with weekly data on the ongoing vaccination campaign.
“Our experts acknowledge that the data is preliminary, but the numbers are very good,” Maccabi said.
To date, about 2.5 million have been vaccinated with the first dose of coronavirus in Israel. people: more than a quarter of the total population. Almost a million have already received the second dose.
Ten out of 20 infected people experienced only mild symptoms such as headache, cough, and general weakness or fatigue. Nobody ended up in the hospital, nobody had a fever.
Photo by Scanpix / Pfizer / BioNTech Coronavirus Vaccine
Maccabi also calculated that the number of new infections and shunts decreased by as much as 60% two days after the second dose. Again, quarantine may be affected here as well, but the effect of the vaccination may already be being felt.
To date, about 2.5 million have been vaccinated with the first dose of coronavirus in Israel. people: more than a quarter of the total population. Almost a million have already received the second dose. There is not much left, as children under the age of 16 who do not get vaccinated account for about 30 percent. of the entire population.
In other places, vaccination rates are slower. On January 15, Pfizer announced that changes were needed at its vaccine plant in Belgium to increase vaccine production starting in mid-February.
Such statements could confuse the EU’s vaccine-based vaccination programs, which require two doses to be effective at intervals of several weeks.
Scanpix Photo / AstraZeneca vaccine
Another storm emerged from AstraZeneca’s statement that the company’s vaccine “will be lower than expected”, even if the EU gives the green light for its use in the Community on Friday.
The company explained this by “reduced productivity at the production site within our European supply chain”, but did not provide further details.
These clarifications are not appropriate in the EU, countermeasures are being considered to control or restrict exports of vaccines from the Community.
[ad_2]
